IMMUNOLOGICAL STUDIES OF MEMBRANE ANTIGENS

膜抗原的免疫学研究

基本信息

  • 批准号:
    3179482
  • 负责人:
  • 金额:
    $ 15.96万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1975
  • 资助国家:
    美国
  • 起止时间:
    1975-05-01 至 1990-04-30
  • 项目状态:
    已结题

项目摘要

The long-term objective of these studies is to define selected antigens of human cells using antibodies produced in non-human primates. The immunological perspective of the non-human primates should allow the recognition of epitopes on these antigens which may be difficult to be detected by lower mammalian species. The specific aims for this renewal period are to: (1) establish the optimal conditions and method for production of chimpanzee monoclonal antibodies to selected human normal and malignant cell antigens; (2) establish the optimal conditions and methods for the in vitro transfection or infection of chimpanzee cells with oncogenes or human tumor DNA; and (3) from aim 2, establish the immunogenicity of tumorigenicity of chimpanzee cells that show evidence of gene insertion or changes in vitro growth characteristics. Specifically, aim 1 will evaluate various methods of chimpanzee B-cell fusion such as electrofusion and PEG, varying the conditions for fusion and growth as well as the parental human and murine myeloma lines to be used as fusion partners. In particular, aim 2 will evaluate various in vitro methods of gene insertion including transfection and infection of chimpanzee fibroblast, epithelial cells, or lymphocytes. Aim 3 will utilize standard injection and serological procedures adapted in this laboratory to induce and measure the autologous immune response in chimpanzees to human gene insertion, their in vitro growth properties, and the nature of the insertion technique. (CS)
这些研究的长期目标是确定选定的抗原

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RICHARD S METZGAR其他文献

RICHARD S METZGAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RICHARD S METZGAR', 18)}}的其他基金

DIFFERENTIATION ANTIGENS OF HUMAN PANCREATIC TUMORS
人胰腺肿瘤的分化抗原
  • 批准号:
    3191178
  • 财政年份:
    1988
  • 资助金额:
    $ 15.96万
  • 项目类别:
DIFFERENTIATION ANTIGENS OF HUMAN PANCREATIC TUMORS
人胰腺肿瘤的分化抗原
  • 批准号:
    3191180
  • 财政年份:
    1988
  • 资助金额:
    $ 15.96万
  • 项目类别:
DIFFERENTIATION ANTIGENS OF HUMAN PANCREATIC TUMORS
人胰腺肿瘤的分化抗原
  • 批准号:
    3191179
  • 财政年份:
    1988
  • 资助金额:
    $ 15.96万
  • 项目类别:
TUMOR IMMUNOLOGY
肿瘤免疫学
  • 批准号:
    3532348
  • 财政年份:
    1980
  • 资助金额:
    $ 15.96万
  • 项目类别:
TUMOR IMMUNOLOGY
肿瘤免疫学
  • 批准号:
    3532354
  • 财政年份:
    1980
  • 资助金额:
    $ 15.96万
  • 项目类别:
TUMOR IMMUNOLOGY
肿瘤免疫学
  • 批准号:
    3532355
  • 财政年份:
    1980
  • 资助金额:
    $ 15.96万
  • 项目类别:
TUMOR IMMUNOLOGY
肿瘤免疫学
  • 批准号:
    3532349
  • 财政年份:
    1980
  • 资助金额:
    $ 15.96万
  • 项目类别:
IMMUNOLOGICAL STUDIES OF MEMBRANE ANTIGENS
膜抗原的免疫学研究
  • 批准号:
    3179481
  • 财政年份:
    1975
  • 资助金额:
    $ 15.96万
  • 项目类别:
IMMUNOLOGICAL STUDIES OF MEMBRANE ANTIGENS
膜抗原的免疫学研究
  • 批准号:
    3179478
  • 财政年份:
    1975
  • 资助金额:
    $ 15.96万
  • 项目类别:
IMMUNOLOGICAL STUDIES OF MEMBRANE ANTIGENS
膜抗原的免疫学研究
  • 批准号:
    3179480
  • 财政年份:
    1975
  • 资助金额:
    $ 15.96万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 15.96万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 15.96万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了